Results 211 to 220 of about 882,867 (351)

Urinary markers in heart failure – types, timing and thresholds. European Journal of Heart Failure expert consensus document

European Journal of Heart Failure, EarlyView.
Pathophysiologic mechanisms of heart failure (HF) (i.e. renin–angiotensin–aldosterone system [RAAS], congestion, and inflammation), together with patient‐related factors such as diabetes, hypertension, and chronic kidney disease (CKD), contribute to kidney function decline and glomerular or tubular injury.
Masatake Kobayashi, Biykem Bozkurt, Peder Langeland Myhre, Juan Carlos Lopez Azor, Mateusz Guzik, Gracjan Iwanek, Guillaume Baudry, Marta Cobo‐Marcos, Òscar Miró, Jeroen Dauw, Piotr Ponikowski, Wilfried Mullens, Alberto Palazzuoli, Marco Metra, Jan Biegus   +14 more
wiley   +1 more source

Obesity-Induced Loss of Function of Bone Marrow Mesenchymal Stromal Cells Is Linked to Cellular Stress and Irreversible at Advanced Stages. [PDF]

J Cell Mol Med
Polat EG, Şeker ME, Pervin B, Ulum B, Aerts-Kaya F.   +4 more
europepmc   +1 more source

Pharmacologic pitfalls in heart failure: A guide to drugs that may cause or exacerbate heart failure. A European Journal of Heart Failure expert consensus document

European Journal of Heart Failure, EarlyView.
Main categories of harmful drugs in heart failure. CCB, calcium channel blocker; DPP4i, dipeptidyl peptidase‐4 inhibitor; HER2‐TT, human epidermal growth factor receptor 2‐targeted therapy; NSAID, non‐steroidal anti‐inflammatory drug; TKI, tyrosine kinase inhibitor; TZD, thiazolidinedione; VEGF Inh, vascular endothelial growth factor inhibitor.
Amr Abdin, Johann Bauersachs, Magdy Abdelhamid, Suleman Aktaa, Hussam Al Ghorani, Antonio Bayes‐Genis, Jan Biegus, Michael Böhm, Javed Butler, Nicolas Girerd, Marco Metra, Wilfried Mullens, Hadi Skouri, Muthiah Vaduganathan, Seif El Hadidi, Giuseppe M.C. Rosano, Gianluigi Savarese   +16 more
wiley   +1 more source

Correction: Epigenome-wide association study of objectively measured physical activity in peripheral blood leukocytes

BMC Genomics
Nicolas Fragoso-Bargas, Nancy S. Mcbride, Sindre Lee-Ødegård, Deborah A. Lawlor, Paul D. Yousefi, Gunn-Helen Moen, Julia O. Opsahl, Anne Karen Jenum, Paul W. Franks, Rashmi B. Prasad, Elisabeth Qvigstad, Kåre I. Birkeland, Kåre R. Richardsen, Christine Sommer   +13 more
doaj   +1 more source

Atypical juxtaglomerular cell tumor in a young male with resistant hypertension and normal renin-aldosterone levels. [PDF]

Urol Case Rep
Dadpour M, Besharati S, Saeedi N, Zabihi MS, Hosseinjani E, Kamranmanesh M, Paeizi R, Ahmadi N, Mohammadi Torbati P.   +8 more
europepmc   +1 more source

Outcomes After Laparoscopic Roux-en-Y Gastric Bypass for Morbid Obesity

Annals of Surgery, 2000
P. Schauer, S. Ikramuddin, W. Gourash, R. Ramanathan, J. Luketich   +4 more
semanticscholar   +1 more source

Severity of effect considerations regarding the use of mutation as a toxicological endpoint for risk assessment: A report from the 8th International Workshop on Genotoxicity Testing (IWGT)

Environmental and Molecular Mutagenesis, EarlyView.
Abstract Exposure levels without appreciable human health risk may be determined by dividing a point of departure on a dose–response curve (e.g., benchmark dose) by a composite adjustment factor (AF). An “effect severity” AF (ESAF) is employed in some regulatory contexts.
Barbara L. Parsons, Marc A. Beal, Kerry L. Dearfield, George R. Douglas, Min Gi, B. Bhaskar Gollapudi, Robert H. Heflich, Katsuyoshi Horibata, Michelle Kenyon, Alexandra S. Long, David P. Lovell, Anthony M. Lynch, Meagan B. Myers, Stefan Pfuhler, Alisa Vespa, Andreas Zeller, George E. Johnson, Paul A. White   +17 more
wiley   +1 more source

Coronary vasodilator capacity in obesity and morbid obesity - divergent flow responses with left ventricular hypertrophy. [PDF]

Int J Cardiol Heart Vasc
Ozkan E, Dai L, Dehdashti F, Liu K, Schindler TH.   +4 more
europepmc   +1 more source

Cardiovascular morbidity following epilepsy: A nationwide retrospective cohort study in South Korea

Epilepsia Open, EarlyView.
Abstract Objective This study evaluated the long‐term risk of major cardiovascular diseases (CVDs) in patients with epilepsy using a nationwide cohort, aiming to address critical gaps in population‐based evidence on brain–heart interactions. Methods Data from the Korean National Health Insurance Service (2002–2013) were analyzed.
Youngoh Bae, Chaeyoon Kang, Yejin Lee, Haerim Cho, Hohyun Jung, Seung Won Lee   +5 more
wiley   +1 more source

Erratum to: Laparoscopic Sleeve Gastrectomy Versus Laparoscopic Roux-En-Y Gastric Bypass for Morbid Obesity and Related Comorbidities: A Meta-Analysis of 21 Studies

Obesity Surgery, 2014
Yong Zhang, Ju Wang, Xiangyu Sun, Z. Cao, Xin-chao Xu, Daquan Liu, Xiangyang Xin, M. Qin   +7 more
semanticscholar   +1 more source